Jul 31, 2018
Pfizer's Retacrit, the First Erythropoietin Stimulating Agent to be FDA Approved, Not Likely to See Rapid Adoption in the US Dialysis Market
Jul 13, 2018
Cerapedics Announces Closing of $22 Million Financing
Jun 06, 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine® (sargramostim) for the Treatment of Acute Radiation Syndrome
May 31, 2018
Biosimilars in Nephrology: Pfizer's Retacrit Gets FDA Clearance and Prepares to Challenge Amgen's Anemia Franchise Head On
May 24, 2018
ATL1103 Phase II trial results published in the European Journal of Endocrinology
May 18, 2018
Growth Factors (Blood and Tissue) - 2018 Global Strategic Business Report Analysis & Forecasts (2016-2024) - Burgeoning Global Population Offers Significant Growth Opportunities
May 15, 2018
FDA approves first epoetin alfa biosimilar for the treatment of anemia
May 08, 2018
The US Renal Anemia Market Sees Some Shifting As Mircera Use Expands Beyond Fresenius Medical Care Clinics and Auryxia Makes its Debut with a New Iron Deficiency Anemia Indication in the Pre-Dialysis Setting
Apr 27, 2018
Bolder BioTechnology Announces Positive Results from Phase 1 Clinical Trial of BBT-015, a Long-Acting G-CSF Analog, in Healthy Volunteers
Apr 09, 2018
Supporting Cells in the Heart Contribute to Cardiac Disease
Feb 23, 2018
Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hypophosphatemia in Children
Feb 07, 2018
Global Erythropoietin Drugs Market 2017-2025 by Drug & Application Type - A $19.65 Billion Market Opportunity
Jan 17, 2018
Researchers Discover Structure of Anti-Aging Hormone
Dec 15, 2017
Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children
Dec 07, 2017
Erythropoietin Drugs Market Value to Reach US$19,379.2 Million by the end of 2025: Transparency Market Research
Oct 24, 2017
Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch 'At Home With Joan' To Empower Patients Battling Cancer
Aug 29, 2017
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H2 2017
Aug 02, 2017
Bolder BioTechnology Announces Initiation of Phase 1 Clinical Trial of BBT-015 for Treating Neutropenia and Acute Radiation Syndrome
Jun 22, 2017
Erythropoietin (EPO) Drugs Market to Reach $17.4 Billion by 2025 - Number of People Suffering From Anemia Expected to Increase - Research and Markets
Jun 22, 2017
Erythropoietin Drugs Market Size Worth $17.4 Billion by 2025: Grand View Research, Inc.